Evaluation value of HIF-1, AFP-L3 and sPD-L1 in patients with primary liver cancer and the efficacy of TACE combined with sorafenib
ZHANG Yong-hong, SHEN Yu-chneg, LU Ying-ying, CHEN Guo-dong
Chinese Hepatolgy . 2024, (11): 1368 -1373 .